收藏切换
Synthetic biological manufacturing of pharmaceuticals
收藏切换
PDF
Xiaoling TANG1, 2, Jucan GAO1, Renchao ZHENG1, 2, Yuguo ZHENG1, 2, *
Science & Technology Review | 2025, 43(23) : 33 - 39
Less
收藏切换
Science & Technology Review | 2025, 43(23): 33-39
Exclusive
Synthetic biological manufacturing of pharmaceuticals
Full
Xiaoling TANG1, 2, Jucan GAO1, Renchao ZHENG1, 2, Yuguo ZHENG1, 2, *
Affiliations
  • 1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China
  • 2State Key Laboratory of Green Chemical Synthesis and Transformation Technology, Hangzhou 310014, China
Published: 2025-12-13 doi: 10.3981/j.issn.1000-7857.2025.09.00034
Outline
收藏切换

China's pharmaceutical industry has made remarkable progress in development, yet it also faces significant challenges in technological innovation and industrial upgrading. This paper provides a systematic overview of the technological architecture underlying synthetic biomanufacturing, highlighting its core advantages grounded in the use of renewable feedstocks, environmentally benign processes, and superior atom economy. On this basis, the paper offers an in−depth discussion of the innovative applications and recent advancements of synthetic biomanufacturing in the synthesis of chemical active pharmaceutical ingredients, bioactive constituents of modernized traditional Chinese medicine, and macromolecular therapeutics including proteins and antibodies. Despite its promising outlook, the field still faces key constraints such as suboptimal technology translation efficiency, barriers to interdisciplinary integration, and limited end−to−end process consolidation across the value chain. To overcome these limitations, it is imperative to strengthen AI−enabled enzyme engineering and metabolic pathway optimization, while promoting deeper convergence with materials science, chemical engineering, and related disciplines to establish next−generation biomanufacturing platforms. In conclusion, synthetic biomanufacturing represents both a strategic driver and an indispensable pathway for advancing China's pharmaceutical industry toward greater precision, efficiency, and intelligence, thereby reinforcing its global competitiveness.

pharmaceutical industry  /  synthetic biological manufacturing  /  biocatalysis  /  microbial cell factory  /  green manufacturing
Xiaoling TANG, Jucan GAO, Renchao ZHENG, Yuguo ZHENG. Synthetic biological manufacturing of pharmaceuticals[J]. Science & Technology Review, 2025 , 43 (23) : 33 -39 . DOI: 10.3981/j.issn.1000-7857.2025.09.00034
Year 2025 volume 43 Issue 23
PDF
1455
966
Cite this Article
BibTeX
Article Info
doi: 10.3981/j.issn.1000-7857.2025.09.00034
  • Receive Date:2025-09-05
  • Online Date:2025-12-26
  • Published:2025-12-13
Article Data
Affiliations
History
  • Received:2025-09-05
  • Revised:2025-11-18
  • Accepted:2025-11-19
Funding
Affiliations
    1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China
    2State Key Laboratory of Green Chemical Synthesis and Transformation Technology, Hangzhou 310014, China
References
Share
https://castjournals.cast.org.cn/joweb/kjdb/EN/10.3981/j.issn.1000-7857.2025.09.00034
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT